Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea. [electronic resource]
Producer: 19980224Description: 1633-8 p. digitalISSN:- 0889-2229
- Adult
- Anti-HIV Agents -- therapeutic use
- Antigens, CD -- metabolism
- CD4 Lymphocyte Count
- Didanosine -- therapeutic use
- Drug Therapy, Combination
- Female
- HIV Infections -- drug therapy
- Humans
- Hydroxyurea -- therapeutic use
- Kinetics
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- metabolism
- Receptors, Tumor Necrosis Factor, Type II
- Reverse Transcriptase Inhibitors -- therapeutic use
- Solubility
- Stavudine -- therapeutic use
- Tumor Necrosis Factor-alpha -- metabolism
- Viremia
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.